Skip to main content
OpenTrials
Recruiting

NCT Number: NCT06564402

Augmentation of Exposure Using Positive Mental Rehearsal in Individuals With Increased Social Anxiety

Efficacy of an optimized exposure therapy training is investigated in individuals with heightened social anxiety. Participants will undergo a one-session standardized exposure training, followed by either standard or positive mental rehearsal of the exposure experience. The efficacy is measured by symptom improvement according to subjective ratings one week later.

Recruiting

Interested in participating?

Request Info

Key information

Age range

18 year and older

Sex eligibility

All sexes

Study type

Interventional

Phase

Not applicable

Primary location

Germany Philipps University

Marburg, 35037, Germany

Location status: Recruiting

Location contact

Andrea Stoliarov, M.Sc.

CONTACT

[email protected]

+4964212826991

Andrea Stoliarov, M.Sc.

PRINCIPAL_INVESTIGATOR

Christiane Melzig, PhD

PRINCIPAL_INVESTIGATOR

Christoph Benke, PhD

CONTACT

[email protected]

+4964212824091

Christoph Benke, PhD

PRINCIPAL_INVESTIGATOR

About this study

Exposure therapy is widely recognized as the gold-standard treatment for anxiety disorders, but its clinically significant response rates remain around 50%. Thus, innovative approaches are needed to improve the efficacy of exposure therapy. One strategy is the mental rehearsal of exposure treatment as a way of supporting the retrieval and consolidation of the exposure memory, which has been demonstrated to be an effective supplement to exposure therapy in a recent study. New conceptualizations also emphasize the role of reward processing and its importance in extinction learning. Several strategies have been proposed to target these reward processes to improve the outcomes of exposure therapy. The present study will examine the use of a positive-focused rehearsal strategy. Participants in the optimized exposure group will engage in an imaginal recounting task focusing on the positive aspects (i.e. emotions, thoughts, behavior) of the exposure. Rehearsal of the positive aspects may increase positive affect, with positive mood thought to be associated with deeper mental rehearsal of stored information. Therefore, the efficacy of using positive mental rehearsal (i.e., imaginal recounting) post-exposure will be investigated, with the use of standard mental rehearsal as an active control group. Participants will be asked to repeat the rehearsal experience at home at two-day intervals. Post-treatment assessment will be conducted one week later. The study will be conducted on healthy participants with an elevated level of social anxiety. The aim of this randomized controlled trial in healthy individuals with increased social anxiety is to investigate whether optimized exposure training (exposure + positive mental rehearsal) is more effective in reducing fear of social interaction compared to an active control group (exposure + mental rehearsal).

Who can participate

Healthy volunteers accepted: Yes

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • Elevated score on Social Interactions Anxiety Scale (SIAS) > 26

Exclusion criteria

  • Current psychotherapeutic/psychiatric treatment
  • Plans to start psychotherapeutic/psychiatric treatment in upcoming weeks
  • Current suicidal intent
  • Severe cardiovascular, respiratory or neurological diseases

Treatment and study plan

Positive Mental Rehearsal

Behavioral

After exposure trial, participants are asked about the positive aspects of their exposure experience (e.g., thoughts, feelings), based on which an imagination script is formulated and recounted

Mental Rehearsal

Behavioral

After exposure, participants are asked about what happened during the exposure experience and whether their central concerns/expected outcome actually occurred during exposure

Exposure

Behavioral

All participants complete exposure exercises (i.e., talking on the phone and talking with a stranger) before positive mental rehearsal is executed

Primary outcomes

  1. Social Interaction Anxiety Scale (SIAS)

    Time frame: Change from baseline to post-treatment (i.e., 7-9 days)

    20-item questionnaire on a 5-point Likert scale (0 = 'not at all'; 4 = 'very strongly') assessing severity of anxiety experienced in social interactions and situations. Total score range: 0 to 80. Higher scores indicate higher severity of social anxiety.

  2. Liebowitz Social Anxiety Scale (LSAS)

    Time frame: Change from baseline to post-treatment (i.e., 7-9 days)

    2-items from the Liebowitz Social Anxiety Scale (LSAS) on a 4-point Likert scale (fear: 0 = 'none'; 3 = 'high'; avoidance: 0 = 'never'; 3 = 'usually') assessing fear and avoidance of the in the intervention exposed situations. Higher scores indicating greater level of fear and avoidance.

  3. Communication Anxiety Inventory (CAI) - Trait Version

    Time frame: Change from baseline to post-treatment (i.e., 7-9 days)

    21-item questionnaire on a 4-point Likert scale (0 = 'almost never'; 3 = 'almost always') assessing an individual's general level of anxiety in communication situations. Total range score: 0 to 84. Higher scores indicate greater level of communication anxiety.

Secondary outcomes

  1. Communication Anxiety Inventory (CAI) - State Version

    Time frame: Baseline

    20-item questionnaire on a 4-point Likert scale (0 = 'not at all'; 3 = 'very strongly' assessing an individual's level of anxiety related to a specific communication situation.

  2. Positive and Negative Affect Schedule (PANAS)

    Time frame: Change from baseline to post-treatment (i.e., 7-9 days)

    20-item questionnaire on a 5-point Likert scale (0 = 'not at all'; 4 = 'extremely' assessing the presence and intensity of both positive and negative emotions. Total score range for positive affect (PA) and negative affect (NA), respectively: 0 to 50. Higher scores indicate on either scale indicate a higher level of that emotion.

  3. Post-Event Processing Inventory (PEPI) - Trait Version

    Time frame: Change from baseline to post-treatment (i.e., 7-9 days)

    12-item questionnaire on a 5-point Likert scale (0 = 'strongly disagree; 4 = 'strongly agree') assessing an individual's general tendency to engage in post-event processing. Total score range: 0 to 60. Higher total scores indicate a greater tendency to ruminate or engage in negative post-event processing.

  4. Post-Event Processing Inventory (PEPI) - State Version

    Time frame: Post-treatment

    12-item questionnaire on a 5-point Likert scale (0 = 'strongly disagree; 4 = 'strongly agree') assessing an individual's level of rumination or post-event processing related to a specific context/situation. Total score range: 0 to 60. Higher total scores indicate a greater engagement in rumination and post-event processing.

  5. Plymouth Sensory Imagery Questionnaire (PSI-Q)

    Time frame: Baseline

    21-item questionnaire across five modalities (visual, auditory, olfactory, gustatory, tactile, and kinesthetic imagery) on a 10-point Likert scale (0 = 'not at all'; 9 = 'mental image as clear and vivid as in real life') assessing how intensively and in detail people can imagine sensory experiences in their mind. Total score range: 0 to 210. Higher total scores indicate a more vivid and detailed sensory imagination.

  6. Snaith-Hamilton-Pleasure-Scale (SHAPS)

    Time frame: Change from baseline to post-treatment (i.e., 7-9 days)

    14-item questionnaire on a 4-point Likert scale (0 = 'strongly disagree'; 3 = 'strongly agree') measuring anhedonia. Scores are transformed to a dichotomous scale: 0 = absence of anhedonia; 1 = presence of anhedonia). Total score range: 0 to 14. Higher total scores indicate greater levels of anhedonia.

Study contacts

Contact information is provided by the study sponsor or research team.

Andrea Stoliarov, M.Sc.

CONTACT

[email protected]

+4964212826991

Christoph Benke, PhD

CONTACT

[email protected]

+4964212824091

Sponsors and collaborators

Lead sponsor

Philipps University Marburg

Other

Registry information

Acronym: APEX

Important dates

Study start
2024
Primary completion
2026
Study completion
2026
First posted
Aug 21, 2024
Registry last updated
Jan 9, 2026

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.